The performance highlights in Exhibit 1 include ORTHOWORLD estimates for segment sales and growth on an as-reported basis for all companies except Anika Therapeutics, ConforMIS, ConMed, Orthofix, OrthoPediatrics, SeaSpine and Vericel. Those companies report in line with the market segment segments that we cover: Joint Reconstruction, Spine, Trauma, Arthroscopy/Soft Tissue Repair and Orthobiologics.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1H18 vs. 1H17 ($MM)
Company
1H18
1H17
$ Chg
% Chg
Alphatec Spine
$43.3
$52.4
($9.1)
(17.4%)
Anika
$45.7
$44.7
$1.0
2.2%
ConforMIS
$38.8
$38.9
($0.2)
(0.5%)
ConMed
$219.0
$209.4
$9.6
4.6%
DePuy Synthes
$4,511.0
$4,567.9
($56.9)
(1.2%)
DJO Surgical
$142.0
$121.0
$21.0
17.4%
Globus Medical
$347.8
$308.2
$39.6
12.8%
Integra
$55.2
$56.6
($1.2)
(2.5%)
K2M
$141.5
$127.6
$13.9
10.9%
Mazor Robotics
$15.5
$11.7
$3.8
32.5%
Medtronic
$787.0
$759.0
$28.0
3.7%
NuVasive
$542.1
$508.4
$33.7
6.6%
Orthofix
$220.3
$211.7
$8.6
4.1%
OrthoPediatrics
$27.2
$21.6
$5.6
25.9%
SeaSpine
$69.6
$66.1
$3.5
5.3%
Smith & Nephew
$1,736.1
$1,660.9
$75.2
4.5%
Stryker
$3,472.6
$3,230.9
$241.7
7.5%
Vericel
$26.2
$17.9
$8.3
46.4%
Wright Medical
$403.9
$356.9
$47.0
13.2%
Zimmer Biomet
$3,714.8
$3,613.1
$101.7
2.8%
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
The performance highlights in Exhibit 1 include ORTHOWORLD estimates for segment sales and growth on an as-reported basis for all companies except Anika Therapeutics, ConforMIS, ConMed, Orthofix, OrthoPediatrics, SeaSpine and Vericel. Those companies report in line with the market segment segments that we cover: Joint Reconstruction, Spine,...
The performance highlights in Exhibit 1 include ORTHOWORLD estimates for segment sales and growth on an as-reported basis for all companies except Anika Therapeutics, ConforMIS, ConMed, Orthofix, OrthoPediatrics, SeaSpine and Vericel. Those companies report in line with the market segment segments that we cover: Joint Reconstruction, Spine, Trauma, Arthroscopy/Soft Tissue Repair and Orthobiologics.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1H18 vs. 1H17 ($MM)
Company
1H18
1H17
$ Chg
% Chg
Alphatec Spine
$43.3
$52.4
($9.1)
(17.4%)
Anika
$45.7
$44.7
$1.0
2.2%
ConforMIS
$38.8
$38.9
($0.2)
(0.5%)
ConMed
$219.0
$209.4
$9.6
4.6%
DePuy Synthes
$4,511.0
$4,567.9
($56.9)
(1.2%)
DJO Surgical
$142.0
$121.0
$21.0
17.4%
Globus Medical
$347.8
$308.2
$39.6
12.8%
Integra
$55.2
$56.6
($1.2)
(2.5%)
K2M
$141.5
$127.6
$13.9
10.9%
Mazor Robotics
$15.5
$11.7
$3.8
32.5%
Medtronic
$787.0
$759.0
$28.0
3.7%
NuVasive
$542.1
$508.4
$33.7
6.6%
Orthofix
$220.3
$211.7
$8.6
4.1%
OrthoPediatrics
$27.2
$21.6
$5.6
25.9%
SeaSpine
$69.6
$66.1
$3.5
5.3%
Smith & Nephew
$1,736.1
$1,660.9
$75.2
4.5%
Stryker
$3,472.6
$3,230.9
$241.7
7.5%
Vericel
$26.2
$17.9
$8.3
46.4%
Wright Medical
$403.9
$356.9
$47.0
13.2%
Zimmer Biomet
$3,714.8
$3,613.1
$101.7
2.8%
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
